India Resurgence Fund, promoted by Piramal Enterprises and Bain Capital Credit, has invested ₹992 crore in drug firm Panacea Biotec..This investment is structured by way of non-convertible debentures (NCDs) of up to ₹864 crore and subscription amount of ₹32 crore towards share warrants to be allotted on a preferential basis, reported Mint..Trilegal and Ropes & Gray acted for the investors..TrilegalPartnerCounselAssociatesCorporate Nishant Parikh, Anirudh Agarwala, Arjun Ghose, Kunaal Shah Sneha Vardhan, Tejas AdigaSenior Associates: Anshul Gosavi, Samira Lalani, Aakriti Shakdher, Sneha Agnihotri, Deep Choudhuri, Rahil PereiraAssociates: Kartik Adhlakha, Snigdha Guha Roy, Srirang Sapre, Deepan Shah, Payal Desai, Ritwik Dash, Akshaya Venkataraman, Gazzal Bishnoi, Vaibhavi Shaunak, Maitreya Shaunak, Nayan Jain, Vruiti Patel, Vaishali Movva.Shardul Amarchand Mangaldas & Co advised Panacea Biotec.Sam & CoPartnerAssociatesCorporateAbhinav BhalaikPrincipal Associate: Daryush Marfatia, Senior Associates: Neekesh Shetty, Gaurav Dugar, Associates: Chirag Shah, Purva Phadke, Tanay Khanna, Harshvardhan Sunder and Gauri Pathak.Due DiligenceAbhinav Bhalaik Mukul BavejaSenior Associates:Asmita Kerkar, Neekesh ShettyAssociates: TanveeVasudevan, Devika Menon, Avni Merchant, Purva Phadke, Shradha NigamBanking & FinanceSapan Gupta Soummo BiswasSenior Associate: G. Meenakshi Associate: Swati Lal.Khaitan & Co acted for one of the promoters of the company..Bar & Bench is available on WhatsApp. For real-time updates on stories, click here to subscribe to our WhatsApp..Follow Bar and Bench channel on WhatsAppDownload the Bar and Bench Mobile app for instant access to the latest legal news.
